Tyra Biosciences, Inc.

US$21.15As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:TYRAHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR 3.68%
Div yield —
ROE (45.31%)
Biotechnology
Beta (5Y) 0.67
PE TTM —
TSR TTM 33.52%
Mkt cap US$1.454B
ROIC (30.05%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$26
22.09%
(31.47%)
Hold 2|2|10|4|0
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.35
0.38
0.41
0.40
3.03%
13.81%
22.56%
25.13%
Revenue$M
145.4
144.3
148.0
148.9
5.92%
3.90%
2.87%
5.04%
Peers (US$1.454B)
Cap (US$)
PE
1.451B
—
Capital
TTM
5Y
10Y
Leveragex
0.497
0.915
0.751
EBIT/Intx
3.975
0.554
0.506
Own earn%
4.12
41.83
41.78
Sh yield%
36.93
35.06
35.99
Owners
Insiders/Inst%
11.55
60.88
Short interest%
1.64
SBC / revenue%
4.80
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
11–19
$1 testx
—
Incr. ROIC%
4